Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.

about

Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.

Item

http://www.wikidata.org/entity/Q53698038

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Linezolid pharmacokinetics in ...... is and Monte Carlo simulation.

@en

Linezolid pharmacokinetics in ...... is and Monte Carlo simulation.

@nl

type

Item

label

Linezolid pharmacokinetics in ...... is and Monte Carlo simulation.

@en

Linezolid pharmacokinetics in ...... is and Monte Carlo simulation.

@nl

prefLabel

Linezolid pharmacokinetics in ...... is and Monte Carlo simulation.

@en

Linezolid pharmacokinetics in ...... is and Monte Carlo simulation.

@nl

P1476

Linezolid pharmacokinetics in ...... sis and Monte Carlo simulation

@en

P2093

Eva Maria Hodel

http://www.w3.org/2001/XMLSchema#string

Geraint Davies

http://www.w3.org/2001/XMLSchema#string

Henry Pertinez

http://www.w3.org/2001/XMLSchema#string

Jan-Willem C Alffenaar

http://www.w3.org/2001/XMLSchema#string

John L Johnson

http://www.w3.org/2001/XMLSchema#string

Laura Bonnett

http://www.w3.org/2001/XMLSchema#string

Mathieu Bolhuis

http://www.w3.org/2001/XMLSchema#string

Maxine Caws

http://www.w3.org/2001/XMLSchema#string

Véronique Dartois

http://www.w3.org/2001/XMLSchema#string

P2860

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis

Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis

Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.

Understanding pharmacokinetics to improve tuberculosis treatment outcome.

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.

Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.

Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

P304

1755-1762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1093/JAC/DKY096

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simon Tiberi

James Millard

Derek J Sloan

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29584861

http://www.w3.org/2001/XMLSchema#string

P932

6005026

http://www.w3.org/2001/XMLSchema#string